What's New in DED in 2026? - Scorecard - MDSpire

What's New in DED in 2026?

"It's all about finding what's wrong with <em>your</em> patient

  • January 1, 2026

  • 1 min

Share

Clinical Scorecard: What's New in DED in 2026?

At a Glance

CategoryDetail
ConditionDry Eye Disease (DED)
Key MechanismsIdentification of root causes through a stepped approach.
Target PopulationPatients with dry eye disease.
Care SettingOptometry and ophthalmology clinics.

Key Highlights

  • TFOS DEWS III provides a step-by-step approach to diagnosing DED.
  • New medications targeting specific root causes of DED are emerging.
  • Focus on individualized patient assessment to determine treatment.

Guideline-Based Recommendations

Diagnosis

  • Utilize the TFOS DEWS III step approach to identify root causes.

Management

  • Implement new medications tailored to specific causes of DED.

Monitoring & Follow-up

  • Regularly assess patient response to new treatments.

Risks

  • Consider potential side effects of new medications.

Patient & Prescribing Data

Individuals diagnosed with dry eye disease.

Emphasis on personalized treatment based on root cause analysis.

Clinical Best Practices

  • Adopt the TFOS DEWS III guidelines for comprehensive patient evaluation.
  • Stay updated on emerging therapies for DED.

References

Original Source(s)

What's New in DED in 2026?

  • January 1, 2026

Related Content

Nordic Pharma Announces European Launch of Lacrifill® Canalicular Gel

Novel therapy for dry eye market

  • February 10, 2026

  • 2 min
A Strategic Solution for Dry Eye Patients

Discover how daily disposable lenses can transform the management of dry eye disease in contact lens wearers, enhancing comfort and adherence.

Look Again! Demodex Blepharitis in Closer Focus

Why Demodex blepharitis deserves more attention – and how a quick diagnostic check can improve patient care

  • January 19, 2026

  • 7 min